← Back to Search

Mild ADRA and their caregivers for Alzheimer's Disease

N/A

Recruiting

Led By Jing Wang, PhD

Research Sponsored by Florida State University

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Be older than 18 years old

Timeline

Screening 3 weeks

Treatment Varies

Follow Up at two weeks after deployment of system

Awards & highlights

Study Summary

This trial aims to make life easier for people living with Alzheimer's and their caregivers with audio and radio sensing systems.

Who is the study for?

This trial is for individuals with Alzheimer's Disease and related dementias (ADRD) and their caregivers. It aims to help manage daily care by monitoring activities using a new system called AURA_ALZ, which uses audio and radio sensing technology.Check my eligibility

What is being tested?

The study tests the AURA_ALZ system in participants' homes over two weeks to see if it can reduce caregiver burden by monitoring patients' activities and providing voice reminders. Participants will also give feedback on the system's usability.See study design

What are the potential side effects?

Since this trial involves a non-invasive monitoring system rather than medication, traditional side effects are not expected. However, there may be concerns about privacy or discomfort with technology use that will be assessed.

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ at two weeks after deployment of system

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~at two weeks after deployment of system

This trial's timeline: 3 weeks for screening, Varies for treatment, and at two weeks after deployment of system for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

Acceptability of use of the AURA_ALZ system will be determined

Feasibility of use of the AURA_ALZ system will be determined

Usability of use of the AURA_ALZ system will be determined

Trial Design

1Treatment groups

Experimental Treatment

Group I: Mild ADRA and their caregiversExperimental Treatment1 Intervention

Deployed the AURA_ALZ system at Home

Do I qualify?Apply below to find out

Find a Location

Who is running the clinical trial?

The University of Texas Health Science Center at San AntonioOTHER

453 Previous Clinical Trials

91,420 Total Patients Enrolled

Florida State UniversityLead Sponsor

200 Previous Clinical Trials

31,748 Total Patients Enrolled

University of North Carolina, Chapel HillOTHER

1,508 Previous Clinical Trials

4,190,815 Total Patients Enrolled

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Does this trial restrict its participants to individuals younger than 20 years of age?

"The upper age limit for this trial is 110 years old, with the lowest acceptable age being 18 or above."

Answered by AI

Are there any openings remaining for this experiment?

"As per the information available on clinicaltrials.gov, this study is in its recruitment phase. It was initially posted to the website on November 16th 2022 and underwent a revision as recently as December 5th 2023."

Answered by AI

How many participants are contributing to this research endeavor?

"Correct. According to the information hosted on clinicaltrials.gov, this medical experiment is actively recruiting participants. This trial was first posted on November 16th 2022 and needs 10 patients from one centre in order to move forward with research."

Answered by AI

Are there any eligibility requirements to join this experiment?

"To be eligible for the trial, applicants must have a caregiver and fall between 18 to 110 years of age. A total of 10 people will be admitted into this study."

Answered by AI

Recent research and studies

clinicaltrials.govStudy

ARUA-ALZ - Connecting Audio and Radio SensingmSystems to Improve Care at Home for ADRD

Jing Wang 2022. "ARUA-ALZ - Connecting Audio and Radio SensingmSystems to Improve Care at Home for ADRD". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT06170528.